Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Daiichi Sankyo extends MDS clinical alliance

This article was originally published in Scrip

Executive Summary

Daiichi Sankyohas extended to 2011 its agreement with MDS Pharma Services for the conduct of clinical studies in the US. The partners have completed 100 studies since the alliance was struck in 2002, mostly early-stage work conducted at the Japanese firm's dedicated clinical pharmacology unit within MDS's facility in New Jersey. Work at the 40-bed unit is overseen by Daiichi Sankyo's pharma development operation and supported by staff of the US contract research organisation.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts